Prevalence and associated factors to hepatitis C in hemodialysis patients in Brazil;Prevalência e fatores associados à hepatite C em pacientes de hemodiálise

Revista de Saude Publica

Volumn 38, Issue 2, 2004, Pages 187-193

  Gonçalves de Medeiros, Maria Teresa ^a,c   de Castro Lima, José Milton ^a   de Oliveira Lima, José Wellington ^b   de Holanda Campos, Henry ^a   das Chagas Medeiros, Marta Maria ^a   Coelho Filho, João Macedo ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b STATE UNIVERSITY OF CEARÁ   (Brazil)

^c NONE   (Brazil)

Author keywords

Cross sectional studies; Enzyme linked immunosorbent assay; Hepatitis C antibodies; Hepatitis C, epidemiology; Prevalence; Renal dialysis; Risk factors; Seroconversion; Socioeconomic factors

Indexed keywords

HEPARIN; HEPATITIS C ANTIBODY;

ADOLESCENT; ADULT; AGE; ARTICLE; BLOOD TRANSFUSION; BRAZIL; CHILD; CLINICAL FEATURE; CLINICAL PRACTICE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISINFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGICAL DATA; EXPOSURE; FEMALE; HEALTH CARE FACILITY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFORMATION PROCESSING; INTERVIEW; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL INSTRUMENTATION; MULTIVARIATE ANALYSIS; PATIENT CARE; PERITONEAL DIALYSIS; PREVALENCE; PROTECTIVE CLOTHING; QUESTIONNAIRE; RISK ASSESSMENT; SCREENING TEST; SOCIAL ASPECT; STATISTICAL ANALYSIS; STUDENT T TEST; VIRUS TRANSMISSION;

EID: 2942665498     PISSN: 00348910     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0034-89102004000200006     Document Type: Article

References (21)

1. Barrera JM, Francis B, Ercilla G, Nelles M, Achord D, Darner J, Lee SR. Improved detection of anti-HCV in post-transfusion hepatitis by a third-generation ELISA. Vox Sang 1995;68:15-8.
2. Blumberg A, Zehnder D, Burckhardt JJ. Prevention of hepatitis C infection in haemodialysis units: a prospective study. Nephrol Dial Transplant 1995;10:230-3.
3. Bosmans JL, Nouwen EJ, Behets G, Gorteman K, Huraib SO, Shaheen FA, et al. Prevalence and clinical expression of HCV-genotypes in haemodialysis-patients of two geographically remote countries: Belgium and Saudi-Arabia. Clin Nephrol 1997;36:872-7.
4. Cantù P, Mangano S, Masini M, Limido A, Crovetti G, DeFilippo C. Prevalence of antibodies against hepatitis C virus in a dialysis unit. Nephron 1992;61:337-8.
5. Cendoroglo Neto M, Manzano SI, Canziani ME, Silva AE, Cirenza LF, Sesso R de C, et al. Environmental transmission of hepatitis B and hepatitis C viruses within the hemodialysis unit. Artif Organs 1995;19:251-5.
6. Corcoran GD, Brink NS, Millar CG, Garson JA, Waite J, Deaville R, et al. Hepatitis C virus infection in haemodialysis patients: a clinical and virological study. J Infect 1994;28:279-85.
7. De Lamballerie X, Olmer M, Bouchouareb D, Zandotti C, De Micco P. Nosocomial transmission of hepatitis C virus in haemodialysis patients. J Med Virol 1996;49:296-302.
8. Dimkovic N, Dragicevic P, Lazic N, Radmilovic A. Further evidence for nosocomial spread of hepatitis C virus infection in hemodialys is units [letter]. Nephron 1996;74:488.
9. Gerard C, Vaira D, Maggipinto G, Troonen H, Margraff U, Siquet J, Sondag D. Combination of serological markers to predict the presence or absence of viremia in HCV-seropositive blood donors. Vox Sang 1996;71:58-60.
10. Gilli P, Moretti M, Soffritti S, Marchi N, Malacarne F, Bedani PL, et al. Non-A, non-B hepatitis and anti-HCV antibodies in dialysis patients. Int J Artif Organs 1990;13:737-41.
11. Gilli P, Soffritti S, De Paoli Vitali E, Bedani PL. Prevention of hepatitis C virus in dialysis units. Nephron 1995;70:301-6.
12. Jadoul M, Cornu C, De Strihou CY, The UCL Collaborate Group. Incidence and risk factors for hepatitis C seroconversion in hemodialysis: a prospective study. Kidney Int 1993;44:1322-6.
13. Jadoul M, Cornu C, De Strihou CY, The Universitaires Cliniques St-Luc (UCL) Collaborative Group. Universal precautions prevent hepatitis C virus transmission: a 54 month follow-up of the Belgium multicenter study. Kidney Int 1998;59:1022-5.
14. Kurz P, Kohler H, Meuer S, Hutteroth T, Meyer zum Buschenfelde KH.. Impaired cellular immune responses in chronic renal failure: evidence for a T cell defect. Kidney Int 1986;29:1209-14.
15. Naghettini AV, Daher RR, Martin RM, Doles J, Vanderborght B, Yoshida CF, Rouzere C. Soroprevalência do vírus da hepatite C na população em diálise de Goiânia, GO. Rev Soc Bras Med Trop 1997;30:113-7.
16. Olmer M, Bouchouareb D, Zandotti C, De Micco P, Lamballerie X. Transmission of the hepatitis C virus in na hemodialysis unit: evidence for nosocomial infection. Clin Nephrol 1996;47:263-70.
17. Pinto dos Santos J, Loureiro A, Cendoroglo Neto M, Pereira BJG. Impact of dialysis room and reuse strategies on the incidence of hepatitis C virus infection in haemodialysis units. Nephrol Dial Transplant 1996;11:2017-22.
18. Pujol FH, Ponce JG, Lema MG, Capriles F, Devesa M, Sirit F, et al. High incidence of hepatitis C virus infection in hemodialysis patients in units with high prevalence. J Clin Microbiol 1996;34:1633-6.
19. Sampietro M, Graziani G, Badalamenti S, Salvadori S, Caldarelli R, Como G, Fiorelli G. Detecion of hepatitis C virus in dialysate and in blood ultrafiltrate of HCV-positive patients. Nephron 1994;68:140.
20. Vanderborght BOM, Rouzere C, Ginuino CF, Maertens G, Van Heuverswyn H, Yoshida CFT. High prevalence of hepatitis C infection: a one-year follow-up study. Rev Inst Med Trop 1995;37:175-9.
21. Zeuzem S, Scheuermann EH, Waschk D, Lee JH, Blaser C, Franke A, Roth WK. Phylogenetic analysis of hepatitis C virus isolates from hemodialysis patients. Kidney Int 1996;49:896-902.